Hypoxia/reoxygenation inhibits P2Y11 receptor expression and its immunosuppressive activity in human dendritic cells

Journal of Immunology

Volumn 195, Issue 2, 2015, Pages 651-660

  Chadet, Stéphanie ^a   Ivanes, Fabrice ^a,b   Benoist, Lauriane ^a   Salmon Gandonnière, Charlotte ^c   Guibon, Roseline ^a   Velge Roussel, Florence ^a,d   Babuty, Dominique ^a,b   Baron, Christophe ^a,c,d   Roger, Sébastien ^d   Angoulvant, Denis ^a,b,d  

^a FHU SUPORT   (France)

^b SERVICE DE DERMATOLOGIE   (France)

^c UNIVERSITY HOSPITAL OF TOURS   (France)

^d UNIVERSITÉ DE TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOKINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; MESSENGER RNA; PROTEIN EATP; PURINERGIC P2Y11 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; HIF1A PROTEIN, HUMAN; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; OXYGEN; P2RY11 PROTEIN, HUMAN; PURINERGIC P2 RECEPTOR; SMALL INTERFERING RNA;

ARTICLE; CELL MATURATION; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; MONOCYTE; ORGAN TRANSPLANTATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REOXYGENATION; ANTAGONISTS AND INHIBITORS; CELL HYPOXIA; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION; TIME;

ADENOSINE TRIPHOSPHATE; CELL HYPOXIA; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOSUPPRESSION; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-6; OXYGEN; PRIMARY CELL CULTURE; PURINERGIC ANTAGONISTS; RECEPTORS, PURINERGIC P2; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 84936802149     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500197     Document Type: Article

References (56)

1. Rubartelli, A., and M. T. Lotze. 2007. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol. 28: 429-436.
2. Riteau, N., P. Gasse, L. Fauconnier, A. Gombault, M. Couegnat, L. Fick, J. Kanellopoulos, V. F. J. Quesniaux, S. Marchand-Adam, B. Crestani, et al. 2010. Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. Am. J. Respir. Crit. Care Med. 182: 774-783.
3. Chen, Y., R. Corriden, Y. Inoue, L. Yip, N. Hashiguchi, A. Zinkernagel, V. Nizet, P. A. Insel, and W. G. Junger. 2006. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 314: 1792-1795.
4. 11 receptor activation. Blood 116: 4492-4500.
5. Pelegrin, P., and A. Surprenant. 2006. Pannexin-1 mediates large pore formation and interleukin-1b release by the ATP-gated P2X7 receptor. EMBO J. 25: 5071-5082.
6. Turer, A. T., and J. A. Hill. 2010. Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. Am. J. Cardiol. 106: 360-368.
7. Eltzschig, H. K., and T. Eckle. 2011. Ischemia and reperfusion-from mechanism to translation. Nat. Med. 17: 1391-1401.
8. Dong, X., S. Swaminathan, L. A. Bachman, A. J. Croatt, K. A. Nath, and M. D. Griffin. 2007. Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int. 71: 619-628.
9. Maekawa, Y., N. Mizue, A. Chan, Y. Shi, Y. Liu, S. Dawood, M. Chen, F. Dawood, G. de Couto, G. H. Li, et al. 2009. Survival and cardiac remodeling after myocardial infarction are critically dependent on the host innate immune interleukin-1 receptor-associated kinase-4 signaling: A regulator of bone marrow-derived dendritic cells. Circulation 120: 1401-1414.
10. Arslan, F., D. P. de Kleijn, and G. Pasterkamp. 2011. Innate immune signaling in cardiac ischemia. Nat. Rev. Cardiol. 8: 292-300.
11. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18: 767-811.
12. Tsung, A., N. Zheng, G. Jeyabalan, K. Izuishi, J. R. Klune, D. A. Geller, M. T. Lotze, L. Lu, and T. R. Billiar. 2007. Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury. J. Leu-koc. Biol. 81: 119-128.
13. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
14. Serbina, N. V., T. P. Salazar-Mather, C. A. Biron, W. A. Kuziel, and E. G. Pamer. 2003. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19: 59-70.
15. Steinman, R. M., and J. Banchereau. 2007. Taking dendritic cells into medicine. Nature 449: 419-426.
16. Anzai, A., T. Anzai, S. Nagai, Y. Maekawa, K. Naito, H. Kaneko, Y. Sugano, T. Takahashi, H. Abe, S. Mochizuki, et al. 2012. Regulatory role of dendritic cells in postinfarction healing and left ventricular remodeling. Circulation 125: 1234-1245.
17. Gündüz, D., S. A. Kasseckert, F. V. Härtel, M. Aslam, Y. Abdallah, M. Schäfer, H. M. Piper, T. Noll, and C. Schäfer. 2006. Accumulation of extracellular ATP protects against acute reperfusion injury in rat heart endothelial cells. Car-diovasc. Res. 71: 764-773.
18. Rayah, A., J. M. Kanellopoulos, and F. Di Virgilio. 2012. P2 receptors and immunity. Microbes Infect. 14: 1254-1262.
19. La Sala, A., D. Ferrari, S. Corinti, A. Cavani, F. Di Virgilio, and G. Girolomoni. 2001. Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses. J. Immunol. 166: 1611-1617.
20. Marteau, F., N. S. Gonzalez, D. Communi, M. Goldman, J.-M. Boeynaems, and D. Communi. 2005. Thrombospondin-1 and indoleamine 2, 3-dioxygenase are major targets of extracellular ATP in human dendritic cells. Blood 106: 3860-3866.
21. Di Virgilio, F. 2005. Purinergic mechanism in the immune system: A signal of danger for dendritic cells. Purinergic Signal. 1: 205-209.
22. Schnurr, M., F. Then, P. Galambos, C. Scholz, B. Siegmund, S. Endres, and A. Eigler. 2000. Extracellular ATP and TNF- A synergize in the activation and maturation of human dendritic cells. J. Immunol. 165: 4704-4709.
23. Iyer, S. S., W. P. Pulskens, J. J. Sadler, L. M. Butter, G. J. Teske, T. K. Ulland, S. C. Eisenbarth, S. Florquin, R. A. Flavell, J. C. Leemans, and F. S. Sutterwala. 2009. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc. Natl. Acad. Sci. USA 106: 20388-20393.
24. 7 receptor activation enhances SK3 channels-and cystein cathepsin-dependent cancer cells invasiveness. Oncogene 30: 2108-2122.
25. Chadet, S., B. Jelassi, R. Wannous, D. Angoulvant, S. Chevalier, P. Besson, and S. Roger. 2014. The activation of P2Y2 receptors increases MCF-7 breast cancer cells migration through the MEK-ERK1/2 signalling pathway. Carcinogenesis 35: 1238-1247.
26. von Kügelgen, I. 2006. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol. Ther. 110: 415-432.
27. Bianchi, B. R., K. J. Lynch, E. Touma, W. Niforatos, E. C. Burgard, K. M. Alexander, H. S. Park, H. Yu, R. Metzger, E. Kowaluk, et al. 1999. Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur. J. Pharmacol. 376: 127-138.
28. + microglia drive neuropathic pain. Nat. Neurosci. 15: 1068-1073.
29. 7 and the inflammasome. Trends Pharmacol. Sci. 28: 465-472.
30. Kornum, B. R., M. Kawashima, J. Faraco, L. Lin, T. J. Rico, S. Hesselson, R. C. Axtell, H. Kuipers, K. Weiner, A. Hamacher, et al. 2011. Common variants in P2RY11 are associated with narcolepsy. Nat. Genet. 43: 66-71.
31. Sakowicz-Burkiewicz, M., K. Kocbuch, M. Grden, I. Maciejewska, A. Szutowicz, and T. Pawelczyk. 2013. High glucose concentration impairs ATP outflow and immunoglobulin production by human peripheral B lymphocytes: involvement of P2X7 receptor. Immunobiology 218: 591-601.
32. Wilkin, F., P. Stordeur, M. Goldman, J.-M. Boeynaems, and B. Robaye. 2002. Extracellular adenine nucleotides modulate cytokine production by human monocyte-derived dendritic cells: dual effect on IL-12 and stimulation of IL-10. Eur. J. Immunol. 32: 2409-2417.
33. Nian, M., P. Lee, N. Khaper, and P. Liu. 2004. Inflammatory cytokines and postmyocardial infarction remodeling. Circ. Res. 94: 1543-1553.
34. Low, P. C., S. Manzanero, N. Mohannak, V. K. Narayana, T. H. Nguyen, D. Kvaskoff, F. H. Brennan, M. J. Ruitenberg, M. Gelderblom, T. Magnus, et al. 2014. PI3Kd inhibition reduces TNF secretion and neuroinflammation in a mouse cerebral stroke model. Nat. Commun. 5: 3450.
35. Beigi, R., E. Kobatake, M. Aizawa, and G. R. Dubyak. 1999. Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase. Am. J. Physiol. 276: C267-C278.
36. Bours, M. J. L., E. L. R. Swennen, F. Di Virgilio, B. N. Cronstein, and P. C. Dagnelie. 2006. Adenosine 59-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther. 112: 358-404.
37. Bosseto, M. C., P. V. B. Palma, D. T. Covas, and S. Giorgio. 2010. Hypoxia modulates phenotype, inflammatory response, and leishmanial infection of human dendritic cells. APMIS 118: 108-114.
38. Kawaguchi, M., M. Takahashi, T. Hata, Y. Kashima, F. Usui, H. Morimoto, A. Izawa, Y. Takahashi, J. Masumoto, J. Koyama, et al. 2011. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation 123: 594-604.
39. Mortensen, R. M. 2012. Immune cell modulation of cardiac remodeling. Circulation 125: 1597-1600.
40. Yan, X., A. Anzai, Y. Katsumata, T. Matsuhashi, K. Ito, J. Endo, T. Yamamoto, A. Takeshima, K. Shinmura, W. Shen, et al. 2013. Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J. Mol. Cell. Cardiol. 62: 24-35.
41. Naito, K., T. Anzai, Y. Sugano, Y. Maekawa, T. Kohno, T. Yoshikawa, K. Matsuno, and S. Ogawa. 2008. Differential effects of GM-CSF and G-CSF on infiltration of dendritic cells during early left ventricular remodeling after myocardial infarction. J. Immunol. 181: 5691-5701.
42. Hall, B. M. 1991. Cells mediating allograft rejection. Transplantation 51: 1141-1151.
43. Sadeghi, M., V. Daniel, R. Weimer, M. Wiesel, O. Hergesell, and G. Opelz. 2003. Pre-transplant Th1 and post-transplant Th2 cytokine patterns are associated with early acute rejection in renal transplant recipients. Clin. Transplant. 17: 151-157.
44. Horn, F., C. Henze, and K. Heidrich. 2000. Interleukin-6 signal transduction and lymphocyte function. Immunobiology 202: 151-167.
45. Liang, Y., K. Christopher, P. W. Finn, Y. L. Colson, and D. L. Perkins. 2007. Graft produced interleukin-6 functions as a danger signal and promotes rejection after transplantation. Transplantation 84: 771-777.
46. de Vries, D. K., J. H. N. Lindeman, D. Tsikas, E. de Heer, A. Roos, J. W. de Fijter, A. G. Baranski, J. van Pelt, and A. F. M. Schaapherder. 2009. Early renal ischemia-reperfusion injury in humans is dominated by IL-6 release from the allograft. Am. J. Transplant. 9: 1574-1584.
47. Fischer, S., A. A. Maclean, M. Liu, J. A. Cardella, A. S. Slutsky, M. Suga, J. F. Moreira, and S. Keshavjee. 2000. Dynamic changes in apoptotic and ne-crotic cell death correlate with severity of ischemia-reperfusion injury in lung transplantation. Am. J. Respir. Crit. Care Med. 162: 1932-1939.
48. Rodrigues, W., M. Carr, D. Ridout, K. Carter, S. L. Hulme, J. Simmonds, M. Elliott, A. Hoskote, M. Burch, and K. L. Brown. 2011. Total donor is-chemic time: relationship to early hemodynamics and intensive care morbidity in pediatric cardiac transplant recipients. Pediatr. Crit. Care Med. 12: 660-666.
49. Ganeshan, K., and A. Chawla. 2014. Metabolic regulation of immune responses. Annu. Rev. Immunol. 32: 609-634.
50. Brahimi-Horn, M. C., and J. Pouysségur. 2009. HIF at a glance. J. Cell Sci. 122: 1055-1057.
51. Koshiji, M., and L. E. Huang. 2004. Dynamic balancing of the dual nature of HIF-1a for cell survival. Cell Cycle 3: 853-854.
52. Rosenberger, P., J. Khoury, T. Kong, T. Weissmüller, A. M. Robinson, and S. P. Colgan. 2007. Identification of vasodilator-stimulated phosphoprotein (VASP) as an HIF-regulated tissue permeability factor during hypoxia. FASEB J. 21: 2613-2621.
53. Zheng, W., J. Kuhlicke, K. Jäckel, H. K. Eltzschig, A. Singh, M. Sjöblom, B. Riederer, C. Weinhold, U. Seidler, S. P. Colgan, and J. Karhausen. 2009. Hypoxia inducible factor-1 (HIF-1)-mediated repression of cystic fibrosis transmembrane conductance regulator (CFTR) in the intestinal epithelium. FASEB J. 23: 204-213.
54. Ronkainen, V.-P., R. Skoumal, and P. Tavi. 2011. Hypoxia and HIF-1 suppress SERCA2a expression in embryonic cardiac myocytes through two interdependent hypoxia response elements. J. Mol. Cell. Cardiol. 50: 1008-1016.
55. Balogh, J., A.-K. Wihlborg, H. Isackson, B. V. Joshi, K. A. Jacobson, A. Arner, and D. Erlinge. 2005. Phospholipase C and cAMP-dependent positive inotropic effects of ATP in mouse cardiomyocytes via P2Y11-like receptors. J. Mol. Cell. Cardiol. 39: 223-230.
56. Djerada, Z., H. Peyret, S. Dukic, and H. Millart. 2013. Extracellular NAADP affords cardioprotection against ischemia and reperfusion injury and involves the P2Y11-like receptor. Biochem. Biophys. Res. Commun. 434: 428-433.